Pulike Biological Engineering (603566.SS) Stock Price
Pulike Biological Engineering Price
Revenue has compounded at 9.2% per year over the past 16 years to 1.09 B CNY. Earnings per share have grown at 4.4% per year over the last 16 years. Pulike Biological Engineering's net margin stands at 17.0%, down from 22.2% several years earlier. Pulike Biological Engineering currently offers a dividend yield of about 5.83%. The payout ratio is around 111% of earnings. The dividend has grown at 16.7% per year over the past 9 years. Analysts set a median price target of 17.25 CNY, implying 67.6% above the current price. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Pulike Biological Engineering stock price
Pulike Biological Engineering business model & stock analysis
Frequently asked questions about Pulike Biological Engineering
Analysts currently set an average price target of 17.25 CNY for the Pulike Biological Engineering stock (median: 17.25 CNY), implying +67.6 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Pulike Biological Engineering stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Pulike Biological Engineering to generate revenue of 1.03 B CNY and earnings per share of 0.47 CNY.
Converted at the current exchange rate, the Pulike Biological Engineering share trades at 1.37 EUR (10.29 CNY).
The Pulike Biological Engineering share (603566.SS) is listed on 1 stock exchanges, including: Shanghai (603566.SS).
The expected revenue of Pulike Biological Engineering is 1.03 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Pulike Biological Engineering is 161.55 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Pulike Biological Engineering is currently 21.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pulike Biological Engineering stock.
The price-to-sales ratio (P/S) of Pulike Biological Engineering is currently 3.42. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Pulike Biological Engineering stock.
The Eulerpool Quality Score for Pulike Biological Engineering is 4/10.
The ISIN of Pulike Biological Engineering is CNE1000025N0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Pulike Biological Engineering is 603566.SS. The ticker symbol is used to trade Pulike Biological Engineering shares on the stock exchange.
Pulike Biological Engineering stock
Pulike Biological Engineering Peer Group
Pulike Biological Engineering Ticker
Pulike Biological Engineering FIGI
All fundamentals and in-depth analysis of Pulike Biological Engineering
Our stock analysis for Pulike Biological Engineering stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pulike Biological Engineering. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.